Literature DB >> 14582383

Genotoxic activities of drug-nitrite interaction products.

Gül Ozhan1, Buket Alpertunga.   

Abstract

At first 28 orally administered drugs, considered to be potentially nitrosatable on the basis of their chemical structure, have been nitrosated with nitrite under simulated stomach conditions. A maximum daily dose of each drug was incubated with a nitrite concentration that can be found after a normal meal in the stomach at 37 degrees C over 1 h. Reaction was started at pH 6.8-7.0 and stopped at pH 2.0, so we had the same pH change that occurs in the stomach. Secondly the genotoxic activities of drug-nitrite interaction products were tested by the umu-test with Salmonella typhimurium TA 1535/pSK1002 as tester strain in the presence and absence of metabolic activation. By the umu-test, among the nitrosation products of drugs examined 22 products showed genotoxicity at different levels. Other six products showed negative results by the umu-test.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582383     DOI: 10.1081/dct-120024844

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  3 in total

1.  Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study.

Authors:  Jean D Brender; Martha M Werler; Katherine E Kelley; Ann M Vuong; Mayura U Shinde; Qi Zheng; John C Huber; Joseph R Sharkey; John S Griesenbeck; Paul A Romitti; Peter H Langlois; Lucina Suarez; Mark A Canfield
Journal:  Am J Epidemiol       Date:  2011-11-01       Impact factor: 4.897

2.  The mutagenicity analysis of imidapril hydrochloride and its degradant, diketopiperazine derivative, nitrosation mixtures by in vitro Ames test with two strains of Salmonella typhimurium.

Authors:  Katarzyna Regulska; Marek Murias; Beata Stanisz; Miłosz Regulski
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-02

3.  Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy.

Authors:  Jean D Brender; Katherine E Kelley; Martha M Werler; Peter H Langlois; Lucina Suarez; Mark A Canfield
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.